I disagree with you completely. I am here for the

I disagree with you completely. I am here for the entire fruit basket Lympro, MSPrecise, Nuropro, Phenogard, Eltoprazine, ESS, MANF RP as well as other indications. You are essentially saying all of it is of not much value. If you are here because you think MANF is potentially the greatest therapeutic molecule ever, that's great. But to suggest investors should not be concerned about the day to day share price and how our newly launched diagnostic impacts is ignorant IMO. I am here 1. because I believe MANF has great potential 2. believe Eltoprazine shows promise with a large market 3. I believe ALZ is going to explode and snowball continuously as a main focus priority of BP, small pharm, government, sports science etc. Thus our suite of diagnostics for ALZ can grow to enormous value. 4. Now bc I believe MS precise has promise with a potential large market.....To suggest we should all look at everything outside of MANF as a meal ticket and checking account for MANF progression solely is absurd IMO. Lastly, every investor has the right and should care about the PPS before a split occurs if needed at all again im not going to explain how this is better for shareholders and the strength and outlook of the company! A company with a PPS @.65 with 800 million shares is obviously stronger than where we are at now!